|
|
||||||||
ORIGINAL RESEARCH |
From Evanston Continence Center, Division of Urogynecology and Reconstructive Pelvic Surgery, Northwestern University Medical School, Evanston Northwestern Healthcare, Evanston, Illinois; and Department of Research, Greenville Hospital System, Greenville, South Carolina.
Address reprint requests to: Patrick J. Culligan, MD, Division of Urogynecology and Reconstructive Pelvic Surgery, Department of Obstetrics and Gynecology, University of Louisville Health Sciences Center, 315 East Broadway M-18, Suite 4002, Louisville, KY 40202; E-mail: pculligan{at}louisville.edu.
| ABSTRACT |
|---|
|
|
|---|
METHODS: Ninety women without significant pelvic organ prolapse underwent urodynamic evaluations with both fiberoptic and microtransducer catheters. Maximal urethral closure pressures and "leak point pressures" were repeatedly measured by the two catheters and statistically compared. The order of catheter use was randomized.
RESULTS: Significantly lower mean maximal urethral closure pressures were recorded by the fiberoptic system than by the microtransducer system (28.9 cmH2O ± 17.3 versus 43.2 cmH2O ± 24.9, P < .001). The fiberoptic catheter predicted microtransducer values for maximum urethral closure pressure only within a range of 27 cmH2O. Mean "leak point pressure" recorded by the fiberoptic catheters (66.9 cmH2O ± 2.9) was not significantly different than that recorded by the microtransducer catheters (66.4 cmH2O ± 2.9, P = .97).
CONCLUSION: There is a significant difference between maximum urethral closure pressure values recorded by the microtransducer and fiberoptic catheter systems. No significant difference was found between the two systems in measurement of Valsalva "leak point pressure."
Maximum urethral closure pressure and leak point pressure represent the two urodynamic measurements used most frequently for classifying severity of incontinence, guiding therapy, and evaluating treatment outcomes. Intrinsic sphincter deficiency is a diagnosis based upon a variety of factors including abnormally low maximum urethral closure pressure and leak point pressure values. Intrinsic sphincter deficiency is considered a more severe variety of stress urinary incontinence with higher long-term failure rates when treated with a retropubic urethropexy.1 As a result, in many continence centers, including our own, suburethral sling procedures are considered first-line therapy for intrinsic sphincter deficiency. In contrast, stress incontinence with "normal" urodynamic findings may be effectively corrected by retropubic urethropexy. To properly advise patients regarding these clinical decisions and assess long-term surgical outcomes for various types of incontinence, it is important to evaluate new technologies as they are introduced into the evolving field of urodynamics.
Microtransducer electronic catheters have been widely regarded as the benchmark technology for urodynamic pressure measurement.2 Using a mechanical transducer, these devices convert pressure directly into an electrical signal, which is then transmitted to a recording device. Because microtransducer catheters detect pressure in a unidirectional fashion, lateral orientation of the pressure diaphragm during measurement of maximum urethral closure pressure is necessary to avoid high-pressure artifact resulting from direct force applied by coaptation of the urethral walls.3 Other relative disadvantages of microtransducer catheters include their expense, fragile nature, and the need for routine care to prevent the accumulation of protein deposits along their delicate pressure sensors.
Largely because of these characteristics of microtransducer systems, fiberoptic pressure transducers were introduced as an alternative. Fiberoptic catheters are generally less delicate and require minimal maintenance compared to microtransducer catheters. The Lumax fiberoptic pressure transducer (MedAmicus Inc., Minneapolis, MN), used for this study, contains a silicon diaphragm sensor located near the catheter tip that deflects in response to pressure, modulating the amplitude of a reflected light signal, which is translated into an electrical signal directly related to the initial pressure. Because they are available in both disposable and reusable forms and are much less expensive than microtransducer systems, fiberoptic systems such as the one in our study are widely used by gynecologists for preoperative urodynamic testing.
Previous investigation has shown these two catheter types to be comparable for single-channel cystometry in an animal model4; however, their comparability during multichannel urodynamics testing, particularly with respect to the measurement of maximum urethral closure pressure and leak point pressure, has not been well established. Elser et al5 compared a fiberoptic transducer catheter (FST 200 System, C. R. Bard Inc., Covington, GA) to a microtransducer catheter for measuring urethral pressures among women with genuine stress incontinence. In this study, the fiberoptic system recorded significantly lower mean maximum urethral closure pressure values and pressure transmission ratios, compared with the microtransducer catheter; however, the sample size for this study was relatively small (n = 30), and leak point pressure measurements were not included.
In this prospective cohort study, we compared maximum urethral closure pressure and "leak point pressure" measurements obtained using the disposable LuMax fiberoptic catheter with pressures recorded by a microtransducer catheter (Mikrotip, Millar Instruments Inc., Houston, TX). Our aim was to evaluate the performance of the fiberoptic catheter in comparison to microtransducer pressure-sensing technology, and thereby determine its clinical utility.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Ninety women ranging in age from 26 to 90 years (mean 58) agreed to participate, and all subjects completed the full study protocol. Immediately before each urodynamic study, a random number table was used to determine the order of catheter use for maximum urethral closure pressure measurement. All urodynamic studies were performed with patients in the upright, sitting position. For the microtransducer catheter, the vesical and urethral pressures were simultaneously recorded with a dual-sensor 8-French Millar Mikrotip catheter. Abdominal pressure was recorded with a similar 8-French Millar catheter placed in the vagina. All microtransducer values were recorded with a Urolab 1156 (Life-Tech, Inc., Stafford, TX). The fiberoptic studies were conducted with disposable, 10-French LuMax catheters and recorded by the LuMax urodynamic system.
Maximal urethral closure pressure was defined according to the International Continence Society7; genuine stress incontinence was defined by leakage of urine at the external urethral meatus, during a maximal cough in the absence of a detrusor contraction.8 Maximum urethral closure pressures were measured at maximum cystometric capacity for all patients in the absence of a detrusor contraction. Because the LuMax catheter used in this study had only one fiberoptic transducer, simultaneous measurement of urethral and vesical pressure during maximum urethral closure pressure assessment could not be accomplished. Therefore, the examiners used clinical clues such as urgency and suprapubic discomfort to exclude any values suspected to have been measured during a detrusor contraction. Both catheters were withdrawn through the urethra using a mechanical profilometer set at a speed of 1 mm/second. Four consecutive urethral profiles were performed, allowing the calculation of four maximum urethral closure pressure values per catheter per patient.
To facilitate comparison of "leak point pressures" and minimize the variability associated with this clinical measure, patients performed four consecutive Valsalva maneuvers with both the fiberoptic and microtransducer catheters simultaneously positioned in the bladder. "Leak point pressure" was defined as the lowest pressure required to cause leakage, calculated by subtracting the intravesical resting pressure from the intravesical pressure at the time leakage first occurred. The lowest of these values recorded by each catheter during leakage was reported as the "leak point pressure." If no leakage occurred, the highest pressure recorded during the Valsalva effort was reported as the "leak point pressure." Any measurements recorded during a detrusor contraction were disgarded.
The fiberoptic and microtransducer catheters could not be connected to the same recording system, so we included an informal periodic calibration system in our study protocol. A polyvinyl chloride pressure chamber was constructed, which allowed the delivery of a known amount of pressure to the pressure transducers of the two systems individually. The pressure recorded during each of these calibrations was identical to the known pressure for both the fiberoptic and microtransducer systems. This calibration protocol was performed four times during the study period for each system. Meticulous cleaning and storage techniques were used for the microtransducer catheters at all times during the study period. The fiberoptic catheters were disposable.
Statistical analyses were performed with Minitab 12.1 (Minitab Inc., State College, PA), SPSS for Windows 9.0 (SSPS Inc., Chicago, IL), and SAS Version 8 (SAS Inc., Cary, NC). Differences in mean maximum urethral closure pressure and "leak point pressure" were compared using Student two-tailed t test; the paired t test was used to assess within-subject differences. Intraclass correlation coefficients were used to assess the intrarater reliability of each catheter system (ie, four measures for each patient using each of the two systems); these coefficients were obtained using the SAS Proc Varcomp procedure. Simple linear regression was used to evaluate validity by assessing the ability to statistically predict "actual" pressures from fiberoptic readings. A multiple regression model was used to account for potentially important covariates influencing this predictive relationship. It was not possible to perform prestudy power calculations because no sample data or normal values for maximum urethral closure pressure or leak point pressure were available. Therefore, poststudy power calculations were performed.
| RESULTS |
|---|
|
|
|---|
The mean maximum urethral closure pressure recorded by the fiberoptic catheters (28.9 cmH2O ± 17.3) was significantly lower than that recorded by the microtransducer catheters (43.2 cmH2O ± 24.9, P < .001); the mean difference was 14.1 cmH2O (95% confidence interval [CI] 11.2, 17.0, P < .001). The statistical power to detect this difference was 99%. Figure 1
illustrates the linear regression between average microtransducer and fiberoptic catheter readings for maximum urethral closure pressure. Using fiberoptic readings, the "actual" microtransducer maximum urethral closure pressure values could be predicted only within 27 cmH2O pressure, with 95% CI. The coefficient of determination (R2) for this model was 0.72, indicating that only 72% of the variation in "actual" pressure could be explained by fiberoptic readings. No other potential predictorsincluding age, maximum cystometric capacity, functional urethral length, or the presence of detrusor instabilityadded significantly to the regression, or improved the ability to precisely predict microtransducer from fiberoptic catheter readings. Moreover, the order of catheter use did not influence the recorded difference in maximum urethral closure pressure measurement between the two catheters (P = .57).
|
|
|
| DISCUSSION |
|---|
|
|
|---|
The established "cut-off" value of 20 cmH2O for the diagnosis of "low" urethral closure pressure was originally determined using microtransducer catheters.1 The aim of this study was to determine whether the values obtained for maximum urethral closure pressure with a fiberoptic system were comparable to the microtransducer standard. We found that the LuMax values for maximum urethral closure pressure only predicted the microtransducer readings within a range of 27 cmH2O. These differences were not predictable (ie, no equation could be applied to the fiberoptic values that would consistently predict the microtransducer values). However, when the fiberoptic system was used to simply classify patients as having either "low" or "normal" maximum urethral closure pressures, the negative predictive value of the system was 96% (Table 1
). Therefore, if a clinician used the LuMax fiberoptic catheter system to rule out "low" urethral closure pressure, he or she would be "correct" 96% of the time.
Comparing leak point pressure values recorded by two different catheters is problematic because of the variation between the quality and intensity of individual Valsalva efforts and the technical challenge of recording the precise moment of leakage. To reduce the potentially confounding variables associated with such a comparison, we recorded "leak point pressure" simultaneously with both catheters in the bladder. The limitation of this study design was that clinically relevant leak point pressure values could not be obtained. However, this strategy facilitated comparison and correlation of the two catheter measurements during the same physical event, and eliminated the need to control for differing Valsalva efforts and subtle delays in marking leakage with the hand-held event recorder. We decided that this simultaneous comparison of the two catheter technologies is the most relevant way to assess the utility of the fiberoptic system for measuring leak point pressure.
Our findings will enable clinicians to compare urodynamic indices from these two different pressure-sensing technologies. Because the ideal surgical treatment algorithm for stress incontinence has not been established, clinicians must use their judgment each time they decide to offer a continence surgery to a given patient. Urodynamic studies play a role in the decision-making process, but the values obtained from these studies are only useful if they are comparable to values obtained during previous and future outcomes-based research.
| Footnotes |
|---|
Received September 12, 2000. Received in revised form April 23, 2001. Accepted May 4, 2001.
| REFERENCES |
|---|
|
|
|---|
2. Versi E. Discriminant analysis of urethral pressure profilometry data for the diagnosis of genuine stress incontinence. Br J Obstet Gynaecol 1990;97:2519.[Medline]
3. Anderson RS, Shepherd AM, Feneley RCL. Microtransducer urethral profile methodology: Variations caused by transducer orientation. J Urol 1983;130:72731.[Medline]
4. Chang H, Zeidman EJ, Alarcon A, Rax S. Urodynamic use of fiberoptic microtipped catheter. J Urol 1986;137:9368.
5. Elser DM, London W, Fantl JA, McBride MA, Beck RP. A comparison of urethral profilometry using microtip and fiberoptic catheters. Int Urogynecol J 1999;10:3714.
6. Bump RC, Mattiasson A, Bo K, Brubaker LP, De Lancey JO, Klarskov P, et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol 1996;175:1017.[Medline]
7. Abrams P, Blaivas JG, Stanton SL, Andersen JT. The standardization of terminology of lower urinary tract function. Scand J Urol Nephrol 1988;114(Suppl 1):159.
8. Fantl JA, Hurt WG, Bump RC, Dunn LJ. Urethral axis and sphincteric function. Am J Obstet Gynecol 1986;155: 54458.[Medline]
9. Burch JC. Urethrovaginal fixation to Coopers ligament for correction of stress incontinence, cystocele, and prolapse. Am J Obstet Gynecol 1961;81:28190.[Medline]
10. Weinberger MW, Ostergard DR. Postoperative catheterization, urinary retention, and permanent voiding dysfunction after polytetrafluoroethylene suburethral sling placement. Obstet Gynecol 1996;87:506.[Abstract]
11. Kohli N, Karram MM. Urodynamic evaluation for female urinary incontinence. Clin Obstet Gynecol 1998;41: 67290.[Medline]
12. Bump RC, Elser DM, Theofrastous JP, McClish DK. Valsalva leak point pressures in women with genuine stress incontinence: Reproducibility, effect of catheter caliber, and correlations with other measures of urethral resistance. Am J Obstet Gynecol 1995;173:5517.[Medline]
This article has been cited by other articles:
![]() |
I. E. Nygaard and M. Heit Stress Urinary Incontinence Obstet. Gynecol., September 1, 2004; 104(3): 607 - 620. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |